In wake of mas­sive year-over-year growth, Mod­er­na re­serves its buy­ers seat at the glob­al deals ta­ble

Ex­pan­sion is the name of Mod­er­na’s game — and for CEO Stéphane Ban­cel, “This is just the be­gin­ning.”

The mR­NA biotech leaped to star­dom in 2020 af­ter com­ing up with a next-gen, mR­NA vac­cine that has been used in mil­lions up­on mil­lions of peo­ple to stave off SARS-CoV-2. And af­ter mak­ing bil­lions of dol­lars thanks to the now-FDA ap­proved Spike­vax, the biotech has some am­bi­tions for how it wants to spread its new­found wealth around.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER